Dimensional Fund Advisors
AGN

Dimensional Fund Advisors’s Allergan Inc AGN Stock Holding History

Dimensional Fund Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-311,501
Closed -$66.2M – 3554
2014
Q4 		$66.2M Sell
311,501
-34
-0% -$6.76K 0.04% 540
2014
Q3 		$55.5M Sell
311,535
-118
-0% -$19.6K 0.04% 606
2014
Q2 		$52.8M Buy
311,653
+3,181
+1% +$495K 0.04% 665
2014
Q1 		$38.3M Buy
308,472
+23,959
+8% +$2.92M 0.03% 872
2013
Q4 		$31.6M Buy
284,513
+113
+0% +$10.8K 0.02% 1017
2013
Q3 		$25.7M Sell
284,400
-293
-0.1% -$26.3K 0.02% 1113
2013
Q2 		$24M Buy
+284,693
New +$29.5M 0.02% 1071

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Dimensional Fund Advisors's AGN Position: Q1 2015 in Review

Dimensional Fund Advisors sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 311,501 shares — an estimated $66.2M sold.

Dimensional Fund Advisors first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $66.2M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Dimensional Fund Advisors reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Dimensional Fund Advisors sold 311,501 Allergan Inc shares in Q1 2015, an estimated $66.2M.
  • Dimensional Fund Advisors first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Dimensional Fund Advisors's Allergan Inc position peaked at $66.2M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Dimensional Fund Advisors's 13F filing for Q1 2015, filed 14 May 2015.